Trademarks / Class 5 / RYZENTAMOS

RYZENTAMOS

SN 99228659 never registeredPrincipal RegisterUSPTO TSDR ↗
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
Mark · Trademark
RYZENTAMOS - official mark drawing from the USPTO record

What this record means

The record shows that the application for RYZENTAMOS has been abandoned, so it is not a live or registered mark; the owner listed is RayzeBio, Inc., a Delaware corporation. The filing covered Class 005 pharmaceutical preparations for treating a very wide range of diseases and for diagnostic radiopharmaceuticals, so a later use of a similar name in the same therapeutic or diagnostic drug space would be the closest area of concern. The abandonment means the USPTO record does not give RayzeBio control over every possible use of the word “RYZENTAMOS,” only over the specific goods described. The prosecution history indicates the application proceeded to a Notice of Allowance on Oct 21 2025, but no Statement of Use was filed, leading to an abandonment notice and final abandonment on May 25 2026. The supplied history shows no oppositions, cancellations or court actions, so there are no visible enforcement signals. I'd treat this as a moderate concern if you plan a similar name for pharmaceutical products, but the risk is lower for unrelated goods.

Informational only - not legal advice.

Mark Trademark

RYZENTAMOS
Standard-character drawing · USPTO TSDR, retrieved Sep 03, 2026
Drawing type4 - STANDARD CHARACTER MARK
Filing basisIntent-to-Use (§1(b)).
StatusAbandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.

Key dates

Application filedJun 11, 2025
Published for oppositionAug 26, 2025
Notice of AllowanceOct 21, 2025
Status dateMay 25, 2026

Goods & services

Cl. 005PharmaceuticalsACTIVE

Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations

Owner & representation

OwnerRayzeBio, Inc.
Address5505 Morehouse Drive, Suite 300, San Diego, CALIFORNIA UNITED STATES 92121
EntityCORPORATION - organized in DELAWARE
Attorney of recordXiomara Triana
CorrespondentXiomara Triana
Attorney emailu********@*****.com
Correspondent email2 emails
Correspondent addressPrinceton, NEW
Full details in the report

Prosecution history 3 of 11 events

May 25, 2026
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 25, 2026
ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2025
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
🔒 Full timeline (11 events) in the report

Ask about this record ✦ AI

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search